Genetic Testing and Treatment: Part 1, Neuromuscular Diseases
Genetic/genomic testing and treatment is continually evolving. The goal of this activity is to assist health care professionals (HCPs) in understanding how the vast and growing field of genetic testing can impact the plan of care and treatment for individuals with neuromuscular diseases. The importance of gathering an individual’s comprehensive history and exam, along with use of current available evidence to inform decisions on next steps in evaluation and testing, will be reviewed. Additionally, faculty will discuss the important role of a genetic counselor during the decision-making process.
This activity is jointly provided by OptumHealth Education and UnitedHealthcare.
No commercial support was received for this activity.
To view this activity, you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+ or Adobe Flash Player 9+. Be sure to disable any pop-up blocking software prior to beginning this activity.
This activity is designed to meet the educational needs of case managers, counselors, educators, nurses, nurse practitioners, pharmacists, pharmacy technicians, PAs, physicians, psychologists, social workers, therapists and other HCPs who have an interest in genetic testing and treatment for individuals with neuromuscular diseases.
At the end of this educational activity, participants should be able to:
- Identify resources for up-to-date literature on genetic testing.
- Recognize the ever-changing field of genetic/genomic testing.
- Discuss how genetic testing may influence plans of care for an individual with a focus on those with neuromuscular diseases such as spinal muscular atrophy (SMA), muscular dystrophy and other congenital myopathies.
- Describe the impact of genetic results on the patient and the family.
- Explain the important role a genetic counselor can play in these decisions.
Peter B. Kang, MD, FAAN, FAAP
Child Neurologist and Neuromuscular Specialist
About the presenter
Peter B. Kang, MD is a pediatric neurologist and physician-scientist whose clinical and research interests have focused on neuromuscular disorders for two decades. His research laboratory focuses on the genetics of limb girdle muscular dystrophy and other pediatric neuromuscular disorders, along with the mechanisms of rare muscle diseases including MEGF10 myopathy, and he has published extensively on these subjects. His work has been supported by the National Institutes of Health and the Muscular Dystrophy Association. In 2019, he was awarded a grant from the Centers for Disease Control and Prevention (CDC) to join the MD STARnet consortium and start a center in Florida to conduct epidemiology surveillance for muscular dystrophy. In 2020, he was awarded a grant from the Xtraordinary Joy Foundation to pursue genetic research on a rare X chromosomal deletion disease.
Dr. Kang is an associate editor of Muscle & Nerve and an editorial board member of two other journals: Neurology and Pediatric Neurology. He recently completed two terms on the editorial board of Pediatrics. He is a member and former chair of the executive committee of the Section on Neurology of the American Academy of Pediatrics. He has served on the Board of Directors of the Child Neurology Society, on the Ethics, Law and Humanities Committee of the American Academy of Neurology, and as Secretary-Treasurer of the Massachusetts Medical Society. Prior to his current position he was Associate Professor of Neurology at Harvard Medical School and Director of the Electromyography Laboratory at Boston Children’s Hospital.
Sarah Chart, RN
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Eden Prairie, MN
Disclosures of relevant financial relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those in control of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services relate to the activity content.
OptumHealth Education ensures that the content is independent of commercial bias.
Ms. Chart and Ms. Gleason have indicated that they are employees of and own stock in UnitedHealth Group.
Dr. Kang has disclosed the following:
- Consultant: AveXis and ChromaDex
- Advisory Board: Sarepta Therapeutics
In support of improving patient care, this activity has been planned and implemented by OptumHealth Education and UnitedHealthcare. OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
This activity is approved for 1.00 contact hour ([0.10] CEU) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hour.
Unique Activity Number(s): JA0007123-9999-20-144-L01-P/T
OptumHealth Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
AAPC will honor 1-for-1 CEUs for any live event offering CME credit or AMA PRA Category 1 Credit™. A certificate of attendance or completion is necessary to show participation. The certificate will give the total CMEs possible for the offering. Physicians are advised to claim only the actual hours that they were present during the education. We ask that AAPC-certified members abide by this request also. One hour of instruction is worth 1 CEU.
The Commission for Case Manager Certification has approved this program for a maximum of 1.00 clock hours for Certified Case Managers (CCM).
OptumHealth Education is approved by the American Psychological Association (APA) to offer continuing education for psychologists. OptumHealth Education maintains responsibility for this program. 1.00 CE hour.
As a Jointly Accredited Organization, OptumHealth Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. OptumHealth Education maintains responsibility for this course. Social workers completing this course receive 1.00 live continuing education credits.
Counselors and/or marriage and family therapists
CA: The Board of Behavioral Sciences has deferred CE course approvals to APA and ASWB for its licensees. See those approvals under Psychologists and Social Workers.
Other States: If your state is not specifically listed, nearly all state Counselor and MFT boards accept either APA or ASWB approval, or are reciprocal with other state licensing board approvals, such as those listed below. Check with your board to be sure.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
- 1.00 AAPC
- 1.00 ACPE - Pharmacist
- 1.00 ACPE - Pharmacy Technician
- 1.00 AMA
- 1.00 ANCC
- 1.00 APA
- 1.00 Attendance
- 1.00 CCMC - General
These materials are intended ONLY for those who attended the live webcast held on July 7, 2020.
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and completing the “Post-Activity Assessment”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”